Suppr超能文献

赖氨酸甲基转移酶Set7/9通过Mdm2轴影响基因毒性应激反应。

KMT Set7/9 affects genotoxic stress response via the Mdm2 axis.

作者信息

Lezina Larissa, Aksenova Vasilisa, Fedorova Olga, Malikova Daria, Shuvalov Oleg, Antonov Alexey V, Tentler Dmitri, Garabadgiu Alexander V, Melino Gerry, Barlev Nikolai A

机构信息

Gene Expression Laboratory, Institute of Cytology, Saint-Petersburg, 194064, Russia.

MRC Toxicology Unit, Leicester, LE1 9HN, UK.

出版信息

Oncotarget. 2015 Sep 22;6(28):25843-55. doi: 10.18632/oncotarget.4584.

Abstract

Genotoxic stress inflicted by anti-cancer drugs causes DNA breaks and genome instability. DNA double strand breaks induced by irradiation or pharmacological inhibition of Topoisomerase II activate ATM (ataxia-telangiectasia-mutated) kinase signalling pathway that in turn triggers cell cycle arrest and DNA repair. ATM-dependent gamma-phosphorylation of histone H2Ax and other histone modifications, including ubiquitnylation, promote exchange of histones and recruitment of DNA damage response (DDR) and repair proteins. Signal transduction pathways, besides DDR itself, also control expression of genes whose products cause cell cycle arrest and/or apoptosis thus ultimately affecting the sensitivity of cells to genotoxic stress. In this study, using a number of experimental approaches we provide evidence that lysine-specific methyltransferase (KMT) Set7/9 affects DDR and DNA repair, at least in part, by regulating the expression of an E3 ubiquitin ligase, Mdm2. Furthermore, we show that Set7/9 physically interacts with Mdm2. Several cancer cell lines with inverse expression of Set7/9 and Mdm2 displayed diminished survival in response to genotoxic stress. These findings are signified by our bioinformatics studies suggesting that the unleashed expression of Mdm2 in cancer patients with diminished expression of Set7/9 is associated with poor survival outcome.

摘要

抗癌药物造成的基因毒性应激会导致DNA断裂和基因组不稳定。辐射或拓扑异构酶II的药理学抑制所诱导的DNA双链断裂会激活共济失调毛细血管扩张突变(ATM)激酶信号通路,进而触发细胞周期停滞和DNA修复。组蛋白H2Ax的ATM依赖性γ磷酸化以及包括泛素化在内的其他组蛋白修饰,会促进组蛋白的交换以及DNA损伤反应(DDR)和修复蛋白的募集。除了DDR自身外,信号转导通路还控制其产物会导致细胞周期停滞和/或凋亡的基因的表达,从而最终影响细胞对基因毒性应激的敏感性。在本研究中,我们使用多种实验方法提供了证据,表明赖氨酸特异性甲基转移酶(KMT)Set7/9至少部分地通过调节E3泛素连接酶Mdm2的表达来影响DDR和DNA修复。此外,我们表明Set7/9与Mdm2存在物理相互作用。Set7/9和Mdm2表达呈反向关系的几种癌细胞系在面对基因毒性应激时存活率降低。我们的生物信息学研究表明Set7/9表达降低的癌症患者中Mdm2的过度表达与不良生存结果相关,这些发现具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6583/4694870/dbef71298204/oncotarget-06-25843-g001.jpg

相似文献

1
KMT Set7/9 affects genotoxic stress response via the Mdm2 axis.
Oncotarget. 2015 Sep 22;6(28):25843-55. doi: 10.18632/oncotarget.4584.
3
PR-Set7-dependent lysine methylation ensures genome replication and stability through S phase.
J Cell Biol. 2007 Dec 31;179(7):1413-26. doi: 10.1083/jcb.200706179. Epub 2007 Dec 24.
4
KMT Set7/9 is a new regulator of Sam68 STAR-protein.
Biochem Biophys Res Commun. 2020 May 14;525(4):1018-1024. doi: 10.1016/j.bbrc.2020.03.017. Epub 2020 Mar 13.
6
Requirement for human Mps1/TTK in oxidative DNA damage repair and cell survival through MDM2 phosphorylation.
Nucleic Acids Res. 2016 Feb 18;44(3):1133-50. doi: 10.1093/nar/gkv1173. Epub 2015 Nov 3.
7
8
Set7/9 controls proliferation and genotoxic drug resistance of NSCLC cells.
Biochem Biophys Res Commun. 2021 Oct 1;572:41-48. doi: 10.1016/j.bbrc.2021.07.086. Epub 2021 Jul 31.

引用本文的文献

1
SETD7 Dual Role in Disease and Opportunities for Therapeutic Intervention: Current Perspectives.
J Inflamm Res. 2025 Sep 4;18:12191-12225. doi: 10.2147/JIR.S534623. eCollection 2025.
2
SETD7 drives diabetic endothelial dysfunction through FBXO45-mediated GPX4 ubiquitylation.
Cardiovasc Diabetol. 2025 Apr 24;24(1):178. doi: 10.1186/s12933-025-02740-6.
3
p53: The Multifaceted Roles of Covalent Modifications in Cancer.
Pharmaceuticals (Basel). 2024 Dec 13;17(12):1682. doi: 10.3390/ph17121682.
4
Cyproheptadine inhibits in vitro and in vivo lung metastasis and drives metabolic rewiring.
Mol Biol Rep. 2024 Nov 10;51(1):1139. doi: 10.1007/s11033-024-10033-6.
5
A Review of CAR-T Combination Therapies for Treatment of Gynecological Cancers.
Int J Mol Sci. 2024 Jun 15;25(12):6595. doi: 10.3390/ijms25126595.
6
Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development.
Biol Direct. 2024 May 29;19(1):41. doi: 10.1186/s13062-024-00484-z.
8
The Role of p53 in Nanoparticle-Based Therapy for Cancer.
Cells. 2023 Dec 8;12(24):2803. doi: 10.3390/cells12242803.
9
Flaviviruses in AntiTumor Therapy.
Viruses. 2023 Sep 22;15(10):1973. doi: 10.3390/v15101973.
10
MicroRNAs Differentially Expressed in Actinic Keratosis and Healthy Skin Scrapings.
Biomedicines. 2023 Jun 15;11(6):1719. doi: 10.3390/biomedicines11061719.

本文引用的文献

1
Characterization of novel markers of senescence and their prognostic potential in cancer.
Cell Death Dis. 2014 Nov 20;5(11):e1528. doi: 10.1038/cddis.2014.489.
2
KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress.
Cell Death Differ. 2014 Dec;21(12):1889-99. doi: 10.1038/cdd.2014.108. Epub 2014 Aug 15.
3
Distinct phosphatases antagonize the p53 response in different phases of the cell cycle.
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7313-8. doi: 10.1073/pnas.1322021111. Epub 2014 Apr 7.
5
Crosstalk between ubiquitin and other post-translational modifications on chromatin during double-strand break repair.
Trends Cell Biol. 2014 Jul;24(7):426-34. doi: 10.1016/j.tcb.2014.01.005. Epub 2014 Feb 23.
6
An unexpected journey: lysine methylation across the proteome.
Biochim Biophys Acta. 2014 Dec;1839(12):1395-403. doi: 10.1016/j.bbagrm.2014.02.008. Epub 2014 Feb 20.
8
Lysine-specific modifications of p53: a matter of life and death?
Oncotarget. 2013 Oct;4(10):1556-71. doi: 10.18632/oncotarget.1436.
9
DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity.
Oncotarget. 2013 Sep;4(9):1338-48. doi: 10.18632/oncotarget.1060.
10
Control of the hippo pathway by Set7-dependent methylation of Yap.
Dev Cell. 2013 Jul 29;26(2):188-94. doi: 10.1016/j.devcel.2013.05.025. Epub 2013 Jul 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验